Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Mereo BioPharma Group PLC ADR stock

Learn how to easily invest in Mereo BioPharma Group PLC ADR stock.

Mereo BioPharma Group PLC ADR is a biotechnology business based in the US. Mereo BioPharma Group PLC ADR shares (MREO) are listed on the NASDAQ and all prices are listed in US Dollars. Mereo BioPharma Group PLC ADR employs 49 staff and has a trailing 12-month revenue of around $36.5 million.

How to buy shares in Mereo BioPharma Group PLC ADR

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MREO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Mereo BioPharma Group PLC ADR stock price (NASDAQ: MREO)

Use our graph to track the performance of MREO stocks over time.

Mereo BioPharma Group PLC ADR shares at a glance

Information last updated 2022-09-26.
Latest market close$0.82
52-week range$0.30 - $2.59
50-day moving average $1.22
200-day moving average $1.15
Wall St. target price$577.32
PE ratio 8.417
Dividend yield $0 (0%)
Earnings per share (TTM) $0.10

Buy Mereo BioPharma Group PLC ADR shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Mereo BioPharma Group PLC ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Mereo BioPharma Group PLC ADR price performance over time

Historical closes compared with the close of $0.8236 from 2022-09-26

1 week (2022-09-21) -11.44%
1 month (2022-08-26) -37.61%
3 months (2022-06-28) -45.46%
6 months (2022-03-24) N/A
1 year (2021-09-27) -66.79%
2 years (2020-09-28) -67.95%
3 years (2019-09-27) 3
5 years (2017-09-24) N/A

Is Mereo BioPharma Group PLC ADR stock undervalued or overvalued?

Valuing Mereo BioPharma Group PLC ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mereo BioPharma Group PLC ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Mereo BioPharma Group PLC ADR's P/E ratio

Mereo BioPharma Group PLC ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Mereo BioPharma Group PLC ADR shares trade at around 8x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Mereo BioPharma Group PLC ADR financials

Revenue TTM $36.5 million
Gross profit TTM $18.6 million
Return on assets TTM -13.82%
Return on equity TTM 34.85%
Profit margin 34.9%
Book value $0.75
Market capitalisation $98.5 million

TTM: trailing 12 months

Mereo BioPharma Group PLC ADR share dividends

We're not expecting Mereo BioPharma Group PLC ADR to pay a dividend over the next 12 months.

Mereo BioPharma Group PLC ADR share price volatility

Over the last 12 months, Mereo BioPharma Group PLC ADR's shares have ranged in value from as little as $0.301 up to $2.59. A popular way to gauge a stock's volatility is its "beta".

MREO.US volatility(beta: 0.61)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mereo BioPharma Group PLC ADR's is 0.6112. This would suggest that Mereo BioPharma Group PLC ADR's shares are less volatile than average (for this exchange).

Mereo BioPharma Group PLC ADR overview

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. The company has a collaboration with The University of Texas MD Anderson Cancer Center to evaluate anti-TIGIT therapeutic antibody candidate, etigilimab. Mereo BioPharma Group plc was incorporated in 2015 and is based in London, the United Kingdom. .

Frequently asked questions

What percentage of Mereo BioPharma Group PLC ADR is owned by insiders or institutions?
Currently 0.048% of Mereo BioPharma Group PLC ADR shares are held by insiders and 66.31% by institutions.
How many people work for Mereo BioPharma Group PLC ADR?
Latest data suggests 49 work at Mereo BioPharma Group PLC ADR.
When does the fiscal year end for Mereo BioPharma Group PLC ADR?
Mereo BioPharma Group PLC ADR's fiscal year ends in December.
Where is Mereo BioPharma Group PLC ADR based?
Mereo BioPharma Group PLC ADR's address is: One Cavendish Place, London, United Kingdom, W1G 0QF
What is Mereo BioPharma Group PLC ADR's ISIN number?
Mereo BioPharma Group PLC ADR's international securities identification number is: US5894921072
What is Mereo BioPharma Group PLC ADR's CUSIP number?
Mereo BioPharma Group PLC ADR's Committee on Uniform Securities Identification Procedures number is: 589492107

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site